Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Impact of Ultra-Early Aneurysm Treatment on Outcomes in Patients With Poor Neurological Status After Intracranial Aneurysm Rupture

NCT03894202 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Impact of Ultra-Early Aneurysm Treatment on Outcomes in Patients With Poor Neurological Status After Intracranial Aneurysm Rupture
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
November 1, 2019
Completion date
March 31, 2023
Enrollment
293 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.